JYSB1900293 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2019-10-25 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | Certificate Issued | 2019-12-27 | view |
JYHF1800129 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2018-10-25 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | Certificate Issued | 2018-11-20 | view |
JYHB2100213 | 盐酸尼卡地平注射液 | nicardipine hydrochloride | Injection | Chemical Drugs(5.1) | Supplementary Application | 2021-03-20 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Nipro Pharma Corporation Ise Plant;Ltl Pharma Co Ltd | Certificate Issued | 2021-07-15 | view |
JYHB2100197 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-03-12 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Certificate Issued | 2021-07-09 | view |
JYHB2100196 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-03-12 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Certificate Issued | 2021-07-09 | view |
JYHB2100195 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-03-12 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Certificate Issued | 2021-07-09 | view |
JYHB2002269 | 盐酸尼卡地平注射液 | nicardipine hydrochloride | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-11-11 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Nipro Pharma Corporation Ise Plant;Ltl Pharma Co Ltd | Filed | 2020-11-24 | view |
JYHB2002110 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-10-22 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Filed | 2020-11-05 | view |
JYHB2002109 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-10-22 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Filed | 2020-11-05 | view |
JYHB2002108 | 甲苯磺酸艾多沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-10-22 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Daiichi Sankyo Europe GmbH | Filed | 2020-11-05 | view |
JYHB2002033 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-10-17 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | Filed | 2020-11-02 | view |
JYHB2002032 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-10-17 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | Filed | 2020-11-02 | view |
JYHB2000235 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-03-09 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | In Review | 2020-03-07 | view |
JYHB2000234 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-03-09 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | In Review | 2020-03-07 | view |
JYHB2000233 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-03-18 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | In Review | 2020-03-17 | view |
JYHB2000232 | 洛索洛芬钠贴剂 | loxoprofen sodium | Patch | Chemical Drugs | Supplementary Application | 2020-03-18 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Lead Chemical Co Ltd;Lead Chemical Co LtdHisagane Plant | In Review | 2020-03-17 | view |
JYHB2000040 | 盐酸尼卡地平注射液 | nicardipine hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-01-17 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Nipro Pharma Corporation Ise Plant;Ltl Pharma Co Ltd | Certificate Issued | 2020-02-17 | view |
JYHB1901652 | 盐酸尼卡地平注射液 | nicardipine hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-01-01 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Nipro Pharma Corporation Ise Plant;Astellas Pharma Inc | Filed | 2020-01-13 | view |
JYHB1901651 | 盐酸尼卡地平注射液 | nicardipine hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-01-01 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Nipro Pharma Corporation Ise Plant;Astellas Pharma Inc | Filed | 2020-01-13 | view |
JYHB1901623 | PLX3397 HCl胶囊 | pexidartinib hydrochloride | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2020-01-01 | 第一三共(中国)投资有限公司 | Daiichi Sankyo (CHINA) HOLDINGS Co Ltd;Catalent Cts LLC;Daiichi Sankyo Co Ltd | In Review | 2019-12-31 | view |